- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Central Nervous System Non-Hodgkin Lymphoma
Total 98638 results
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Non-Hodgkins LymphomaCanada
-
SanofiCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin LymphomaUnited States
-
Henan Cancer HospitalRecruitingNon-hodgkin Lymphoma,B CellChina
-
Anne Beaven, MDCTI BioPharmaCompletedNon-Hodgkin's LymphomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.TerminatedNon-Hodgkin's LymphomaUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
Duke UniversityGlaxoSmithKlineCompletedLymphoma, B-CellUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompleted
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Chongqing Precision Biotech Co., LtdPeking University Cancer Hospital & InstituteRecruitingB Cell Lymphoma | Non Hodgkin LymphomaChina
-
Akdeniz UniversityNot yet recruitingNon-Hodgkin Lymphoma | Decision Support System
-
AmgenCompletedCancer | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Thrombocytopenia | Oncology | Chemotherapy-Induced Thrombocytopenia
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
Chinese PLA General HospitalRecruitingNon-hodgkin Lymphoma,B CellChina
-
Spectrum Pharmaceuticals, IncTerminated
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCTerminated
-
Ruijin HospitalUnknownNon-hodgkin Lymphoma,B CellChina
-
Timmune Biotech Inc.UnknownNon-hodgkin Lymphoma,B CellChina
-
Asan Medical CenterSchering-PloughCompletedNon-Hodgkin's LymphomaKorea, Republic of
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
The Cleveland ClinicCompletedLymphoma, B-CellUnited States
-
Altor BioScienceTerminatedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomaUnited States
-
Baylor College of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); The Methodist... and other collaboratorsRecruitingLymphoma | Non-Hodgkin's Lymphoma | Hodgkin's Disease | Lymphoproliferative DiseaseUnited States
-
University Hospital, GenevaActive, not recruitingAggressive B-Cell Non-Hodgkin LymphomaSwitzerland
-
SCRI Development Innovations, LLCInfinity Pharmaceuticals, Inc.CompletedStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesLymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | T-cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory T-Cell Non-Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory Transformed... and other conditionsUnited States
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
NCIC Clinical Trials GroupEli Lilly and CompanyCompleted
-
Chinese PLA General HospitalRecruiting
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Medical University Fourth HospitalRecruiting
-
Stanford UniversityKite PharmaRecruitingNon-Hodgkin Lymphoma | Large B-cell LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Not yet recruitingB-Cell Non-Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
University of California, San FranciscoTerminated
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)RecruitingRecurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Indolent Adult Non-Hodgkin...United States
-
Medical University of South CarolinaRecruitingChronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
St. Jude Children's Research HospitalCompletedLymphoblastic LymphomaUnited States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieUnknownUnresectable Solid Neoplasm | Recurrent Solid Neoplasm | Refractory Mantle Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Advanced Solid Neoplasm | T-Cell Non-Hodgkin LymphomaUnited States
-
Bioray LaboratoriesWuhan Union Hospital, China; Zhejiang University; Institute of Hematology & Blood...RecruitingNon-hodgkin Lymphoma,B CellChina
-
Chinese PLA General HospitalRecruitingNon-hodgkin Lymphoma,B CellChina
-
Spectrum Pharmaceuticals, IncCompletedLymphoma, B-CellUnited States
-
Timmune Biotech Inc.Hunan Provincial People's HospitalUnknownNon-hodgkin Lymphoma,B CellChina
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States
-
PfizerCompletedLymphoma, B-CellUnited States, Spain, France, Switzerland, United Kingdom, Belgium, Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed